(NASDAQ: GNTA) Genenta Science Spa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 73.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 104.81%.
Genenta Science Spa's earnings in 2025 is -$10,116,946.On average, 3 Wall Street analysts forecast GNTA's earnings for 2025 to be -$14,451,754, with the lowest GNTA earnings forecast at -$13,885,019, and the highest GNTA earnings forecast at -$14,876,806. On average, 3 Wall Street analysts forecast GNTA's earnings for 2026 to be -$14,061,166, with the lowest GNTA earnings forecast at -$13,509,748, and the highest GNTA earnings forecast at -$14,474,730.
In 2027, GNTA is forecast to generate -$16,599,988 in earnings, with the lowest earnings forecast at -$15,949,008 and the highest earnings forecast at -$17,088,223.